cdk4 glutathione Diet-metabolism-transcription axis modulates the sensitivity to CDK4/6 inhibitors through RB1 in prostate cancer: Cell Reports Cyclin D-Cdk4,6 Drives Cell-Cycle Progression
Description
Approximately 20.9% of patients on the 12 mg dose reported dysesthesia, a condition involving skin sensitivity, tingling, or tenderness to touch
Mandler M, Valera E, Rockenstein E, Weninger H, Patrick C, Adame A, Santic R, Meindl S, Vigl B, Smrzka O, et al
Once the memory cell is activated, it generates a rapid adaptive immune response
Missing either one produces an incomplete claim
